Sort   by:  
 Page size 
UnknownLighting the wick in the candle of learning: generating a prediction stimulates curiosity.
Not available
S-EPMC6803639 | biostudies-literature
TranscriptomicsAnalysis of the Cerebral Cortex and Hippocampus Transcriptome Reveals Unique Molecular Changes in the Ts1Cje Mouse Model of Down Syndrome
Down syndrome is characterized by a complex phenotype that includes developmental disabilities and congenital anomalies. The molecular origin of these abnormalities is poorly understood. The objective of this study is to analyze whole transcriptome changes in the cortex and hippocampus of the Ts1Cje...
ORGANISM(S): Mus musculus 
2013-09-05 | E-GEOD-49635 | biostudies-arrayexpress
UnknownQuantification of Poly(vinyl chloride) Microplastics via Pressurized Liquid Extraction and Combustion Ion Chromatography.
Not available
S-EPMC10061920 | biostudies-literature
UnknownEvaluation of fiber and debris release from protective COVID-19 mask textiles and in vitro acute cytotoxicity effects.
Not available
S-EPMC9212752 | biostudies-literature
TranscriptomicsAnalysis of the Fetal and Neonatal Transcriptomic and Neurocognitive Phenotype in the Ts1Cje Mouse Model of Down syndrome
Down syndrome is characterized by a complex phenotype that includes developmental disabilities and congenital anomalies emerging during fetal life. The molecular origin of these abnormalities is poorly understood. Despite the evidence of prenatal onset of the phenotype, most therapeutic trials have ...
ORGANISM(S): Mus musculus 
2014-11-15 | E-GEOD-62538 | biostudies-arrayexpress
UnknownGradient-Pattern Micro-Grooved Wicks Fabricated by the Ultraviolet Nanosecond Laser Method and Their Enhanced Capillary Performance.
Not available
S-EPMC10819530 | biostudies-literature
UnknownAutogenic Training for Reducing Chronic Pain: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
Not available
S-EPMC8548271 | biostudies-literature
ProteomicsCerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy
Promising results from recent clinical trials on the approved antisense oligonucleotide nusinersen in pediatric patients with 5q-linked spinal muscular atrophy (SMA) still have to be confirmed in adult patients but are hindered by a lack of sensitive biomarkers that indicate an early therapeutic res...
ORGANISM(S): Homo sapiens (Human) 
2020-01-07 | PXD016757 | Pride
Mass spectrometry (ms) Proteomics Antisense oligonucleotide (aso) Nusinersen Spinal muscular atrophy (sma) Cerebrospinal fluid (csf) 
UnknownHeat shock protein 60 and immune inflammatory responses in atherosclerosis.
Not available
S-EPMC3212728 | biostudies-literature
ProteomicsProteomic characterization of cerebrospinal fluid in patients with brain malignancies
Recent technological advances in molecular diagnostics through liquid biopsies hold the promise to monitor tumor evolution and treatment response of brain malignancies without the need of invasive surgical tissue accrual. Here, we implemented a new mass spectrometry-based protein analysis pipeline a...
ORGANISM(S): Homo sapiens (Human) 
2021-03-25 | PXD021984 | Pride
Brain tumor Glioblastoma Proteome Biomarker 
Sort   by:  
 Page size